The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum

Myostatin, also known as growth and differentiation factor 8, is a member of the transforming growth factor β superfamily that negatively regulates skeletal muscle mass ( 1 ). Recent experiments have shown that myostatin activity is detected in serum by a reporter gene assay only after activation b...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry Vol. 277; no. 43; pp. 40735 - 40741
Main Authors: Hill, Jennifer J, Davies, Monique V, Pearson, Adele A, Wang, Jack H, Hewick, Rodney M, Wolfman, Neil M, Qiu, Yongchang
Format: Journal Article
Language:English
Published: United States American Society for Biochemistry and Molecular Biology 25-10-2002
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Myostatin, also known as growth and differentiation factor 8, is a member of the transforming growth factor β superfamily that negatively regulates skeletal muscle mass ( 1 ). Recent experiments have shown that myostatin activity is detected in serum by a reporter gene assay only after activation by acid, suggesting that native myostatin circulates as a latent complex ( 2 ). We have used a monoclonal myostatin antibody, JA16, to isolate the native myostatin complex from normal mouse and human serum. Analysis by mass spectrometry and Western blot shows that circulating myostatin is bound to at least two major proteins, the myostatin propeptide and the follistatin-related gene (FLRG). The myostatin propeptide is known to bind and inhibit myostatin in vitro ( 3 ). Here we show that this interaction is relevant in vivo , with a majority (>70%) of myostatin in serum bound to its propeptide. Studies with recombinant V5-His-tagged FLRG protein confirm a direct interaction between mature myostatin and FLRG. Functional studies show that FLRG inhibits myostatin activity in a reporter gene assay. These experiments suggest that the myostatin propeptide and FLRG are major negative regulators of myostatin in vivo .
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M206379200